# Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease

> **NCT04433104** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vinmec Research Institute of Stem Cell and Gene Technology** · enrollment: 40 (actual)

## Conditions studied

- COPD

## Interventions

- **BIOLOGICAL:** Umbilical Cord Mesenchymal Stem Cells transplantation
- **DRUG:** drug therapy according to Vietnamese MOHS procedure

## Key facts

- **NCT ID:** NCT04433104
- **Lead sponsor:** Vinmec Research Institute of Stem Cell and Gene Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-09
- **Primary completion:** 2021-07-30
- **Final completion:** 2022-12-25
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04433104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04433104, "Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04433104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*